In this multi-omic analysis of a large pan-cancer cohort, we observed significant tumor type-specific differences in the landscape of molecular alterations as well as a more immune-enriched, or “hot,” microenvironment in TACSTD2-high tumors. This evidence concerns the gene TACSTD2 and neoplasm.